How do doctors make decisions on when to stop, start or change treatment regimes for hepatitis C patients was the subject of a major study undertaken for a world leading pharmaceutical company by Rand Europe and Baird’s CMC. … [Read more...]
Transforming the lives of Hepatitis C patients
How new breakthrough drugs are priced always creates heated debate. Gilead’s new breakthrough drug Sovaldi for hepatitis C was no exception. Here Baird’s CMC Associates at Ward Health, describe the issues and evidence surrounding the introduction of … [Read more...]
Women need HIV protection too: getting an innovative microbicide to market
If you’re sexually active, the best way to protect yourself against HIV infection is to use a condom. Condoms have lots going for them – they are cheap, ubiquitous and have been accepted by men and women as an effective measure against both … [Read more...]